Articles

Podcasts

Videos

Clinical

As much as 2% of vaccine recipients have reported anaphylaxis following their first shot.

Second Dose of COVID-19 mRNA Vaccine Found Safe After Reaction to First

Asymptomatic and symptomatic COVID-19 cases among health care personnel were reduced after vaccination despite surge in infected patients.

Vaccinations Protected Health Care Personnel During Surge of Patients with COVID-19

The agency is expected to make a statement later today on masking recommendations. 

CDC Announces New Mask Recommendations for Vaccinated Individuals Under Certain Circumstances

The nasal mucosa was seen to be an essential determinant of overall disease trajectory.

Response to COVID-19 in Nasopharynx May Determine Disease Severity

The framework could help officials assess the true burden of disease in certain areas.

Modeling the True Prevalence of the COVID-19 Pandemic

Use of remdesivir for COVID-19 was associated with longer hospital stays but was not associated with improved mortality, a recent study of 2344 patients at 123 VA hospitals found.

Remdesivir Did Not Improve Mortality at Hospitals, Prolonged Stays

Modeling showed 1 in 4 infected people pass the infection to a family member.

Antibodies Last at Least 9 Months After COVID-19 Infection 

Pfizer and Moderna will include children aged 5-11 years old in ongoing trials to speak toward risk of rare adverse events observed in other young recipients.

FDA Requires Pediatric COVID-19 mRNA Trials to Include Younger Children

The statement includes over 50 societies and organizations, representing millions of workers.

Major Healthcare Organizations Call for COVID-19 Vaccine Mandates

Communities experiencing such health inequity and disparities are more likely to have mistrust in systems that have continuously failed them. Understanding the perspectives of those disproportionately affected is critical to not only address them, but also work to correct and prevent these disparities moving forward. 

CORONAVIRUS